L. McKenzie

Dose Escalation Study to Assess the Pharmacokinetic Parameters of a Nano-amorphous Oral Sirolimus Formulation in Healthy Volunteers

L. Molnár, T. Solymosi, J. McDermott, 2019, European Journal of Drug Metabolism and Pharmacokinetics.

Dose Finding and Food Effect Studies of a Novel Abiraterone Acetate Formulation for Oral Suspension in Comparison to a Reference Formulation in Healthy Male Subjects

L. Molnár, T. Solymosi, G. Filipcsei, 2021, Pharmaceutics.

Phase I evaluation of the safety, tolerability, and pharmacokinetics of GSK3640254, a next‐generation HIV‐1 maturation inhibitor

Samit R. Joshi, A. S. Krishnatry, G. Ferron-Brady, 2020, Pharmacology research & perspectives.

A phase 1/1b study of PUR1900, an inhaled formulation of itraconazole, in healthy volunteers and asthmatics to study safety, tolerability and pharmacokinetics

Dave Singh, G. Layton, N. Khan, 2019, British journal of clinical pharmacology.

Development of a Prototype, Once-Daily, Modified-Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772

D. Tompson, V. Zann, Geoffrey Johnson, 2021, Pharmaceutical Research.

Development of a Once-Daily Modified-Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772 using DiffCORE Technology

D. Tompson, V. Zann, Geoffrey Johnson, 2022, Pharmaceutical research.